Inactive Instrument
Acticor Biotech SAS Stock Euronext Paris
Stocks
ALACT
FR0014005OJ5
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
CEO | Chief Executive Officer | - | 26/11/2013 |
Francois Guillet
DFI | Director of Finance/CFO | 68 | 13/10/2024 |
Anouar Sari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 26/11/2013 |
Alain Parthoens
BRD | Director/Board Member | 66 | 24/10/2018 |
Catherine Boule
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 12.69M | |
| -0.37% | +1.12% | +57.21% | +84.56% | 72.26B | |
| -0.07% | -2.70% | +37.74% | +86.90% | 60.24B | |
| +0.75% | +0.75% | +36.71% | +21.09% | 27.73B | |
| -0.14% | -2.75% | -14.13% | +356.79% | 25.73B | |
| +0.57% | +1.10% | +1.02% | -2.89% | 24.75B | |
| +1.10% | +1.86% | +25.07% | -7.59% | 20.74B | |
| -1.70% | +0.43% | +150.24% | +323.16% | 15.06B | |
| +0.36% | +2.01% | +49.51% | +160.70% | 14.41B | |
| -2.53% | -8.15% | -6.38% | +483.59% | 14.23B | |
| Average | -0.20% | -0.11% | +37.44% | +167.37% | 30.57B | |
| Weighted average by Cap. | -0.12% | -1.08% | +38.13% | +127.01% |
Employees
31
